Marché du médicament contre l’insuffisance respiratoire : croissance à horizon 2006
27 Sept. 2006, Lyon, Allbizreport.com announces that a new market research is available to its catalog.
This report analyzes the worldwide markets for Respiratory Drugs in US$ Million.
The major product segments analyzed are Asthma, Allergic Rhinitis, and COPD (Chronic Obstructive Pulmonary Disease).
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World.
Annual forecasts are provided for each region for the period of 2000 through 2010.
The report profiles 69 companies including many key and niche players worldwide such as Accentia Biopharmaceuticals, Inc., Aerogen, Inc., Aerovance, Inc., airPharma, AstraZeneca, Aventis Pharma Limited, Bespak, Boehringer Ingelheim Pharmaceuticals, Inc., Cadila Pharmaceuticals, Dr.
Reddy’s Laboratories, EvoGenix, GlaxoSmithKline, GlaxoSmithKline Pharmaceuticals Ltd., Inyx, Inc., The Merck Generics Group, Novartis AG, Pfizer, Inc., Ranbaxy Laboratories Limited, Respironics, Inc., Sandoz International GmbH, and Schering-Plough Corp.
Click the link for more information regarding this market research report
Suivez ce lien pour plus d’information sur cette étude de marché sectorielle
Informations entreprise
